precision medicine summit zeroes in on cost, quality
Top leaders in the emerging field of precision medicine gathered Thursday (Feb. 25) for a day-long summit convened by the Bay Area Council and hosted by Oracle with major support from Genentech. An audience of 200 heard from leading experts about the promise of precision medicine to improve how we treat individual patients, combat disease and bring down the cost of healthcare through scientific and technological advances and the use of Big Data. Delivering on the promise of precision medicine requires the ability to leverage unprecedented amounts of data, and enabling seamless access to that data for researchers and clinicians is one of the most important things we are doing here at Oracle, Oracle CEO Safra Catz said in opening keynote remarks.
Included on the agenda was a conversation on scientific advancements with Joseph DeRisi of the UCSF School of Medicine, Garret Hampton from Genentech and Jonathan Sheldon of Oracle. Genomic CEO Kim Popovits sat down with Blue Shield of California CEO Paul Markovich for a candid and informative conversation on public and private funding of precision medicine. And Bay Area Council Economic Institute (BACEI) President Dr. Micah Weinberg led a discussion on the promise of precision medicine to improve health and lower costs with Dr. Elizabeth Baca from the Governor’s Office of Planning and Research, Manoja Lecamwasam of Dignity Health and Dr. Michael Seiden of McKesson. Dr. Otis Brawley of the American Cancer Society closed out the summit with remarks on the new frontiers that precision medicine is exploring.
To highlight just how important this emerging field is, the Council’s summit coincided with a similar gathering that President Obama convened on Thursday at the White House. To engage in our healthcare policy work, contact BACEI President Micah Weinberg.